Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ProShares Ultra Energy
DIG
5
VanEck Oil Services ETF
OIH
US Stock MarketDetailed Quotes
Spero Therapeutics (SPRO)
- 2.790
- +0.090+3.33%
Trading Jun 12 13:25 ET
161.55MMarket Cap10.33P/E (TTM)
2.805High2.700Low372.93KVolume2.720Open2.700Prev Close1.03MTurnover0.80%Turnover Ratio18.60P/E (Static)57.90MShares3.22052wk High3.05P/B129.80MFloat Cap1.80052wk Low--Dividend TTM46.52MShs Float23.639Historical High--Div Yield TTM3.89%Range %0.505Historical Low2.762Avg Price1Lot Size
About Spero Therapeutics Company
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.
Company Profile
SymbolSPRO
Company NameSpero Therapeutics
Listing DateNov 2, 2017
Issue Price14.00
ISINUS84833T1034
Founded2013
CEOMs. Esther Rajavelu
MarketNASDAQ
Employees25
Fiscal Year Ends12-31
Address675 Massachusetts Avenue,14th floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-857-242-1600
Company Executives
- Name
- Position
- Salary
- Esther Rajavelu
- Director, President, Chief Business Officer, Chief Executive Officer, Principal Accounting Officer, Chief Financial Officer and Treasurer
- 2.06M
- Timothy Keutzer
- Chief Operating Officer
- 1.44M
- Frank E. Thomas
- Chairman of the Board
- 187.80K
- Dr. John C. Pottage,Jr,M.D.
- Director
- 332.80K
- Kathleen Tregoning, M.A.
- Independent Director
- 107.80K
- Cynthia Smith
- Independent Director
- 117.80K
- Scott T. Jackson, M.B.A.
- Independent Director
- 115.30K
- Dr. Patrick V.J.J. Vink, M.D.
- Independent Director
- 141.55K
- Dr. Milind S. Deshpande, PhD
- Independent Director
- 120.30K
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
A critical window for U.S.-Iran talks has opened! According to Bloomberg, the U.S. and Iran are 'close' to signing an agreement around the u
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm